LONG TERM NEED OF IV IRON IN PATIENTS WITH HEREDITARY HAEMORRHAGIC TELANGIECTASIA

被引：0
|
作者：
Ellent, E. [1 ]
Rigby, P. [1 ]
机构：
[1] LSUHSC, New Orleans, LA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2018年 / 66卷 / 02期
关键词：
D O I：
10.1136/jim-2017-000697.216
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
216
引用
收藏
页码：439 / 440
页数：2
相关论文
共 50 条
  • [21] Life expectancy in patients with hereditary haemorrhagic telangiectasia
    Sabbà, C
    Pasculli, G
    Suppressa, P
    D'Ovidio, F
    Lenato, GM
    Resta, F
    Assennato, G
    Guanti, G
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (05) : 327 - 334
  • [22] How to manage patients with hereditary haemorrhagic telangiectasia
    Geisthoff, Urban W.
    Nguyen, Ha-Long
    Roeth, Alexander
    Seyfert, Ulrich
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) : 443 - 452
  • [23] Cerebral screening in patients with hereditary haemorrhagic telangiectasia
    Jackson, A.
    Briggs, T. A.
    Clayton-Smith, J.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (10) : 1047 - 1047
  • [24] A novel treatment for patients with hereditary haemorrhagic telangiectasia
    Farnan, TB
    Gallagher, G
    Scally, CM
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2002, 116 (10): : 849 - 850
  • [25] Mutation screening in patients with hereditary haemorrhagic telangiectasia
    Toydemir, PB
    McDonald, J
    Ward, K
    Mao, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 577 - 577
  • [26] PULMONARY ARTERIOVENOUS MALFORMATIONS, HEREDITARY HAEMORRHAGIC TELANGIECTASIA AND IRON TREATMENTS
    Shovlin, C. L.
    Boother, E. J.
    Fung, C. H.
    Bamford, K. B.
    Layton, D. M.
    Jackson, J. E.
    Brownlow, S.
    THORAX, 2017, 72 : A180 - A180
  • [27] HAEMORRHAGE ADJUSTED IRON-REQUIREMENTS AND EXERCISE CAPACITY IN HEREDITARY HAEMORRHAGIC TELANGIECTASIA PATIENTS
    Soni, A.
    Badiani, N.
    Gawecki, F.
    Finnamore, H.
    Shovlin, C.
    THORAX, 2019, 74 : A156 - A157
  • [28] Cancer and hereditary haemorrhagic telangiectasia
    Hosman, A. E.
    Shovlin, C. L.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (02) : 369 - 370
  • [29] Bevacizumab and hereditary haemorrhagic telangiectasia
    Cruikshank, Ross P.
    Chern, Boris W.
    MEDICAL JOURNAL OF AUSTRALIA, 2011, 194 (06) : 324 - 325
  • [30] Thalidomide for hereditary haemorrhagic telangiectasia
    Franchini, Massimo
    Lippi, Giuseppe
    LANCET HAEMATOLOGY, 2015, 2 (11): : E457 - E458
12345